Becton Dickinson
BDX
$260.87
Share price
-0.03%
Change (1 day)
12.62%
Change (1 year)
Categories
Becton Dickinson, also known as BD, is one of the largest international medical technology companies that develops, produces and sells disposable medical devices, device systems and reagents. BD supplies hospitals, health care facilities, life scientists, clinical laboratories and the pharmaceutical industry.
Becton Dickinson (BDX) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $27.08 B
According to Becton Dickinson's latest financial reports the company's total liabilities are $27.08 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Becton Dickinson - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-09-30 | $27.63 B | -8.47% |
| 2021-09-30 | $30.18 B | -0.16% |
| 2020-09-30 | $30.23 B | -1.4% |
| 2019-09-30 | $30.66 B | -6.82% |
| 2018-09-30 | $32.91 B | 32.78% |
| 2017-09-30 | $24.78 B | 38.07% |
| 2016-09-30 | $17.95 B | -8.66% |
| 2015-09-30 | $19.65 B | 165.82% |
| 2014-09-30 | $7.39 B | 4.04% |
| 2013-09-30 | $7.10 B | -1.63% |
| 2012-09-30 | $7.22 B | 28.97% |
| 2011-09-30 | $5.60 B | 32.88% |
| 2010-09-30 | $4.21 B | 1.3% |
| 2009-09-30 | $4.16 B | 39.78% |
| 2008-09-30 | $2.97 B | 0.34% |
| 2007-09-30 | $2.96 B | -0.7% |
| 2006-09-30 | $2.98 B | 7.18% |
| 2005-09-30 | $2.78 B | 3.85% |
| 2004-09-30 | $2.68 B | 0.35% |
| 2003-09-30 | $2.67 B | 4.81% |
| 2002-09-30 | $2.55 B | 3.19% |
| 2001-09-30 | $2.47 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $50.19 B | 85.34% | 🇺🇸 USA |
 Baxter BAX | $22.25 B | -17.82% | 🇺🇸 USA |
 Hologic HOLX | $4.15 B | -84.65% | 🇺🇸 USA |
 ResMed RMD | $2.62 B | -90.32% | 🇺🇸 USA |
 Teleflex TFX | $2.68 B | -90.10% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | $3.94 B | -85.42% | 🇺🇸 USA |
 Intuitive Surgical ISRG | $1.94 B | -92.82% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $3.53 B | -86.96% | 🇺🇸 USA |